Abstract:Osteoclasts derived from hematopoietic stem cells express immunoreceptors on their cell surface. Previously, we showed that the β‐glucan curdlan suppressed osteoclastogenesis via binding to dectin‐1, a pattern recognition receptor. Curdlan negatively regulates osteoclast differentiation and bone resorption capacity by suppressing the expression of nuclear factor of activated T cells 1 (NFATc1), a master factor for osteoclast differentiation, in a dectin‐1‐dependent manner; however, the mechanism involved in this process has not yet been fully elucidated. In this study, we aimed to elucidate the molecular mechanism involved in the suppression of RANKL‐induced osteoclast differentiation by curdlan. Real‐time RT‐qPCR results showed that curdlan suppressed the expression of NFATc1 in cells of the osteoclast progenitor cell line RAW264.7 overexpressing dectin‐1 (d‐RAW cells), without altering the expression of negative regulators. Therefore, we examined the effect of curdlan on the NF‐κB pathway, which is important for the induction of NFATc1 expression. Western blot analysis results showed that curdlan addition suppressed RANKL‐induced NF‐κB activation in the vector control line (c‐RAW) cells with low expression of dectin‐1, in d‐RAW cells, and the parental RAW264.7 (RAW) cells. The results of tartrate‐resistant alkaline phosphatase staining and real‐time RT‐qPCR showed that curdlan addition suppressed osteoclast differentiation in RAW cells, suggesting the presence of a dectin‐1‐independent modification system. Finally, we focused on the complement receptor 3 (CR3), which binds β‐glucan, and revealed that blocking the binding of β‐glucan to the CD11b molecule, a component of CR3, by neutralizing antibody, recovered the suppression of IκBα degradation by curdlan. These results suggest that the suppression of osteoclast differentiation by curdlan involves not only the dectin‐1‐dependent pathway but also the negative regulation of NFATc1 via modification of the NF‐κB pathway via CR3 recognition. The results of this study may aid to establish treatment methods for metabolic bone diseases and inflammatory bone destruction and to clarify their pathogenesis.

Radiofrequency field inhibits RANKL-induced osteoclast differentiation in RAW264.7 cells via modulating the NF-κB signaling pathway

Mineralizing Solution and Dexamethasone Enhance Receptor Activator for NF-κB Ligand Expression in Rat Bone Marrow Stromal Cells

Administration of SB239063 Ameliorates Ovariectomy-Induced Bone Loss Via Suppressing Osteoclastogenesis in Mice

Nrf2 Mitigates RANKL and M-CSF Induced Osteoclast Differentiation via ROS-Dependent Mechanisms

Crif1 Promotes Osteoporosis in Mice after Radiation

CR6-Interacting Factor-1 Promotes Osteoclastogenesis Through the NF-κB Signaling Pathway after Irradiation.

Radiation Alters Osteoclastogenesis by Regulating the Cytoskeleton and Lytic Enzymes in RAW 264.7 Cells and Mouse Bone Marrow-Derived Macrophages

The emerging role of IMD 0354 on bone homeostasis by suppressing osteoclastogenesis and bone resorption, but without affecting bone formation

The Nrf2 activator RTA-408 attenuates osteoclastogenesis by inhibiting STING dependent NF-κb signaling.

Notopterol Attenuates Estrogen Deficiency-Induced Osteoporosis <i>via</i> Repressing RANKL Signaling and Reactive Oxygen Species

CDDO-Me, Sulforaphane and Tbhq Attenuate the RANKL-induced Osteoclast Differentiation Via Activating the NRF2-mediated Antioxidant Response.

Effect of JAK2/STAT3 Signaling Pathway on RANKL-induced Osteoclastogenesis in RAW264.7 Cells

Mechanical stress directly suppresses osteoclast differentiation in RAW264.7 cells

The Effect of 137cs Γ-Rays on the Differentiation of Human Peripheral Blood Mononuclear Cells to Osteoclast-Like Cells

P2X7 receptor knockdown suppresses osteoclast differentiation by inhibiting autophagy and Ca2+/calcineurin signaling

Molecular Mechanisms of Curdlan‐Induced Suppression of NFATc1 Expression in Osteoclasts

StemRegenin 1 attenuates the RANKL-induced osteoclastogenesis via inhibiting AhR- c-src-NF-κB/p-ERK MAPK-NFATc1 signaling pathway

Suppressing Angiogenesis Regulates The Irradiation-Induced Stimulation On Osteoclastogenesis In Vitro

Irradiation‐induced Osteocyte Damage Promotes HMGB1‐mediated Osteoclastogenesis in Vitro

Inhibition of NFAM1 suppresses phospho-SAPK/JNK signaling during osteoclast differentiation and bone resorption

Downregulated fat mass and obesity-associated protein inhibits bone resorption and osteoclastogenesis by nuclear factor-kappa B inactivation